Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides a financial update on its commercial and operational performance for the quarter ended September 30, 2026 (Q3 2026).
Iranian security chief rules out transferring enriched uranium abroad as Tehran demands U.S. sanctions relief before dialogue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results